Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC

Human Immunology

Volumn 64, Issue 2, 2003, Pages 238-244

  Vidovic, Damir ^a   Graddis, Thomas J ^a   Stepan, Lara P ^a   Zaller, Dennis M ^b   Laus, Reiner ^a  

^a Dendreon   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Accessory molecules; Antigen presenting cells; Coreceptors; Costimulation; T cell hybridomas

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; HLA DR1 ANTIGEN; INTEGRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; HYBRIDOMA; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0037318423     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00780-2     Document Type: Article

References (28)

1. Larson RS, Springer TA: Structure and function of leukocyte integrins. Immunol Rev 114:181, 1990.
2. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7:445, 1989.
3. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ: The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol 7:579, 1989.
4. Böhmig GA, Kovarik J, Holter W, Pohanka E, Zlabinger GJ: Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro. J Immunol 152:3720, 1994.
5. Ramesh P, Barber L, Batchelor JR, Lechler RI: Structural analysis of human anti-mouse H-2E xenorecognition: T cell receptor bias and impaired CD4 interaction contribute to weak xenoresponses. Int Immunol 4:935, 1992.
6. Lombardi G, Barber L, Aichinger G, Heaton T, Sidhu S, Batchelor JR, Lechler RI: Structural analysis of anti-DR1 allorecognition by using DR1/H-2Ek hybrid molecules: Influence of the beta 2-domain correlates with CD4 dependence. J Immunol 147:2034, 1991.
7. Vignali DA, Moreno J, Schiller D, Hammerling GJ: Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med 175:925, 1992.
8. Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, Belunis C, Bolin DR, Arceo R, Campbell R, Falcioni F, Vidovic D, Hammer J, Nagy ZA: HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 183:2635, 1996.
9. Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS: Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A 91:6151, 1994.
10. von Hoegen P, Miceli MC, Tourvieille B, Schilham M, Parnes JR: Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridoma. J Exp Med 170:1879, 1989.
11. Tadaki DK, Craighead N, Saini A, Celniker A, Burkly LC, Lee KP, Chute JP, Harlan DM, Kirk AD: Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity. Transplantation 70:162, 2000.
12. Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlovic S: Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin Cancer Res 6:2175, 2000.
13. Small EJ, Fratesi P, Reese DM, Strang G, Laus R, Peshwa MV, Valone FH: Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J Clin Oncol 18:3894, 2000.
14. Laus R, Yang DM, Ruegg CL, Shapero MH, Slagle PH, Small E, Burch P, Valone F: Dendritic cell immunotherapy of prostate cancer: Preclinical models and early clinical experience. Cancer Res Ther Control 11:1, 2001.
15. Fong L, Brockstedt D, Benike C, Breen JK, Strang G, Ruegg CL, Engelman EG: Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol 167:7150, 2001.
16. Woods A, Chen HY, Trumbauer ME, Sirotina A, Cummings R, Zaller DM: Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med 180:173, 1994.
17. Marrack P: Production of antigen specific H-2 restricted T-cell hybridomas. In: Fathman CG, Fitch FW (eds): Isolation, Characterization and Utilization of T-Lymphocyte Clones. New York: Academic Press, 1982.
18. White J, Blackman M, Bill J, Kappler J, Marrack P, Gold D, Born W: Two better cell lines for making hybridomas expressing specific T cell receptors. J Immunol 143:1822, 1989.
19. Lassila O, Vainio O, Matzinger P: Can B cells turn on virgin T cells? Nature 334:253, 1988.
20. + T-helper and a T-killer cell. Nature 393:474, 1998.
21. + B cell hybridomas to H-2 restricted T cell hybridomas. Proc Natl Acad Sci U S A 79:3604, 1982.
22. Tosato G: Generation of Epstein-Barr virus (EBV) immortalized B cell lines. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology 2. New York: Wiley Interscience, 1998.
23. Vidovic D, Graddis T, Chen F, Slagle P, Diegel M, Stepan L, Laus R: Anti-tumor vaccination with HER-2 derived recombinant antigens. Int J Cancer 102:660, 2002.
24. Pharmingen research product catalog. San Diego: Pharmingen, 1998.
25. Kruisbeek AM: Production of mouse T cell hybridomas. In Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds): Current Protocols in Immunology 1. New York: Wiley Interscience, 1998.
26. Choy EH, Adjaye J, Forrest L, Kingsley GH, Panayi GS: Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes. Eur J Immunol 23:2676, 1993
27. Moscovitch M, Kaufman Y, Berke G: Memory CTL-hybridoma: A model system to analyze the anamnestic response of cytolytic T lymphocytes. J Immunol 133:2369, 1984.
28. Regnier-Vigouroux A, Blanc D, Pont S, Marchetto S, Pierres M: Accessory molecules and T cell activation. J. Antigen receptor avidity differentially influences T cell sensitivity to inhibition by monoclonal antibodies to LFA-1 and L3T4. Eur J Immunol 16:1385, 1986.